Screening Protein Interaction with RNA by Innovative Technologies – SPIRIT
We have recently discovered a new technology that uses microtubules as nanoplatforms to detect biomolecular interactions in cells. This technology is particularly effective in quantifying RNA:protein interactions for which other existing methods offer few alternatives. Here, we propose to develop this technology to screen small molecules to interfere with RNA:protein interactions related to pathological processes. To validate our strategy, we will use an integrative approach combining bionformatics, structural and cellular biology to target a specific RNA:protein complex involved in human cancer. We have already obtained the NMR structure of the RNA:protein complexe targets to probe the action of small molecules in vitro and identified few molecules targeting mRNA:protein interactions in cells. At the end of this project, our results could validate our innovative approach and reveal RNA:protein interactions as putative targets in human diseases.
Project coordination
David PASTRE (STRUCTURE ET ACTIVITE DES BIOMOLECULES NORMALES ET PATHOLOGIQUES)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
SABNP STRUCTURE ET ACTIVITE DES BIOMOLECULES NORMALES ET PATHOLOGIQUES
SYNSIGHT
BioCIS Biomolécules : Conception, Isolement, Synthèse
Help of the ANR 505,011 euros
Beginning and duration of the scientific project:
October 2022
- 42 Months